交易 Axsome Therapeutics Inc - AXSM 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.24
• 长仓隔夜仓息调整: -0.02157%
• 短仓隔夜仓息调整: -0.00065%
• 隔夜调整仓息时间: 22:00 (UTC)
• 货币: USD
• 最低成交量: 0.1
• 保证金: 50.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 184.24
• 开仓: 183.2
• 1 年变化: 44.49%
• 日区间: 180.97 - 186.45

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer''s disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.